Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria
- 27 November 2018
- journal article
- letter
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (5), 1659-1661.e1
- https://doi.org/10.1016/j.jaip.2018.11.018
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaAllergy, 2018
- Benefit of mepolizumab treatment in a patient with chronic spontaneous urticariaJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2018
- Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticariaJournal of the European Academy of Dermatology and Venereology, 2017
- Chronic urticaria: new management optionsWorld Allergy Organization Journal, 2014
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous UrticariaNew England Journal of Medicine, 2013
- High Prevalence of Mental Disorders and Emotional Distress in Patients with Chronic Spontaneous UrticariaActa Dermato Venereologica, 2011